Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 7Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Advanced Gastric Adenocarcinoma 2Uterine Cervical Neoplasms 1Turcot syndrome 1Stomach Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Liver Neoplasms 1Liver Diseases 1Leukemia, Myeloid, Acute 1Immune Checkpoint Inhibition 1ESCC 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Bites and Stings 1Advanced Hepatocellular Carcinoma 1

Interventions

lenvatinib 1camrelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Advanced Hepatocellular Carcinoma × camrelizumab × Clear all
NCT04487704 2022-04-29

Camrelizumab Utilization on Patients With Advanced Liver Cancer

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Unknown
1,000 enrolled
Gastrointestinal

Advanced Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡